ECRM_1170x120_8-1-17

Harvard Drug Group

Cardinal Health wraps up purchase of Harvard Drug

Cardinal Health wraps up purchase of Harvard Drug

DUBLIN, Ohio — Cardinal Health Inc. has closed its $1.115 billion acquisition of pharmaceutical distributor Harvard Drug Group. Cardinal said Monday that the all-cash deal, announced in early June, will boost its generic drug distribution business as well as expand its over-the counter drug product offerings and its telesales programs and capabilities. Harvard Drug also

Harvard Drug Group sold to Cardinal

DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.12 billion. Based in Livonia, Mich., THDG is a distributor of generic drugs, over-the-counter medicines and related products to retail, institutional and alternate care customers. THDG had revenue of about

Cardinal Health to buy Harvard Drug Group

Cardinal Health to buy Harvard Drug Group

DUBLIN, Ohio — Cardinal Health Inc. plans to acquire pharmaceutical distributor The Harvard Drug Group (THDG) from private equity firm Court Square Capital Partners for $1.115 billion. Cardinal said Friday that it will use cash and new debt to finance the transaction, which is expected to close in the beginning of its 2016 fiscal year,